Listed by the USPTO as NOLAN, JASON MICHAEL
Tech Center 1600 • Art Units: 1617 1623 1626 1627 1629 1636
This examiner grants 67% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18832840 | HETEROCYCLIC COMPOUNDS | Non-Final OA | Hoffmann-La Roche Inc. |
| 18462918 | MODULATORS OF THE INTEGRATED STRESS PATHWAY | Final Rejection | AbbVie Inc. |
| 18962163 | DIETARY TRIPROPIONIN SUPPLEMENTATION TO REDUCE ADIPOSITY AND IMPROVE GLUCOSE HOMEOSTASIS | Non-Final OA | Wisconsin Alumni Research Foundation |
| 18033662 | PDE9 INHIBITORS FOR TREATING CARDIAC FAILURE | Final Rejection | Vanderbilt University |
| 18970142 | Imidazole Compounds for Organic Light-Emitting Diodes | Non-Final OA | Arizona Board of Regents on behalf of Arizona State University |
| 18562587 | HETEROCYCLIC COMPOUNDS AND METHODS OF PREPARATION THEREOF | Final Rejection | The Medical College of Wisconsin Inc. |
| 18858318 | BORON COMPOUNDS, RELATED LIPID PARTICLES, LIPOPLEXES, COMPOSITIONS, METHODS OF USE, AND METHODS OF MAKING | Non-Final OA | UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC. |
| 18248858 | HETEROCYCLIC GLP-1 AGONISTS | Non-Final OA | Gasherbrum Bio, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy66.9% of resolved applications examined by Jason Michael Nolan were allowed (390 resolved cases), compared with 34.2% across Art Unit 1617 over the last five years.
This examiner's interview lift is -25.9 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Jason Michael Nolan took 1,000 days on average from filing to allowance.
Jason Michael Nolan examines applications in Art Unit 1617 in Tech Center 1600 (Biotechnology & Pharmaceuticals).